Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam Promotes Greene to President, Zubarev Joins Sage-N-Research's SAB, Cellzome Appoints SAB Members

NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals has promoted Barry Greene from COO to president and COO, the firm announced today. He will continue to report to CEO John Maraganore. Prior to Alnylam, Greene was general manager of oncology at Millennium Pharmaceuticals.

Roman Zubarev has joined Sage-N Research’s scientific advisory board. Zubarev, a professor at Sweden’s Uppsala University, specializes in proteomics, pathway analysis, and mass spectrometry research.

Cellzome this week said it has appointed the members of its scientific advisory board and has named company CSO David Simmons to chair the SAB.
The newly appointed SAB includes:
Spyros Artavanis-Tsakonas, a professor of cell biology at Harvard Medical School and at the College of France;
Christopher Buckley, who is professor of rheumatology at the MRC Centre for Immune Regulation, University of Birmingham;
Sir Philip Cohen, director of the Medical Research Council Protein Phosphorylation Unit at the University of Dundee;
Emilio Hirsch, a professor of applied biology at the Center for Molecular Biotechnology at the University of Torino;
Harren Jhoti, who is founder and CEO of Astex Therapeutics;
Bernhard Kuster, a professor of bioanalytics at the Technical University Munich;
David Middlemiss, founder of the drug discovery consulting company XaviaPharm;
David Sabatini, principal investigator at the Whitehead Institute for Biomedical Research;
Giulio Supert-Furga, who is director of the Center of Molecular Medicine at the Austrian Academy of Sciences;
Arthur Weiss, who is an Ephraim Engleman Distinguished Professor of Rheumatology and is a professor of medicine, microbiology and immunology at the University of California.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.